U.S. Banks Stock News

Cipher Digital recently advanced its shift from bitcoin mining to operating industrial-scale data centers, securing roughly US$11.40 billion in contracted revenue from long-term hyperscale leases, including 300 MW of capacity for Amazon Web Services in Texas. This pivot positions Cipher Digital as a power- and infrastructure-centric partner for AI and high-performance computing workloads, drawing institutional interest toward its extensive energy footprint and hyperscale leasing...

Marvell Technology (MRVL) opened its Q1 2027 scorecard with revenue of US$2.4 billion and basic EPS of US$0.04, alongside net income of US$34.5 million, giving investors a clean read on how the new fiscal year is starting. Over the past six quarters, revenue has moved from US$1.8 billion in Q4 2025 to US$1.9 billion in Q1 2026 and then to US$2.4 billion in Q1 2027. Basic EPS has ranged from US$0.23 to US$2.22 before landing at US$0.04 this quarter, a pattern that puts the focus squarely on...

Why Illumina’s new MRD kit matters for the stock Illumina (ILMN) has drawn fresh attention after launching a whole genome based molecular residual disease research kit that targets both solid tumors and blood cancers, anchored on its NovaSeq X sequencing platform. The solution, currently in early access and backed by initial data from partners such as Mayo Clinic, broadens Illumina’s oncology research offering at a time when the company has been working to address flat sales and weaker...

In recent days, Axon Enterprise reported record Q1 results, raised its 2026 revenue growth outlook to 30%–32%, and highlighted strong demand for TASER 10, Axon Body 4, AI tools, and counter-drone solutions, supported by a new Echodyne partnership to enhance public safety drone programs. Management’s emphasis on fast-growing AI and counter-drone businesses, alongside expanding public safety use cases globally, points to a deeper, more ecosystem-driven revenue mix for Axon. With Axon now...

Omega Healthcare Investors (OHI) is preparing for a major leadership shift, with long-serving CEO C. Taylor Pickett and CFO Bob Stephenson set to retire and internally promoted successors already lined up. See our latest analysis for Omega Healthcare Investors. OHI's share price has softened recently, with the stock down 2.5% over the past week and 2.6% over the past 90 days. However, its 1-year total shareholder return of 36.3% and 3-year total shareholder return of 98.3% highlight how...

Recent performance snapshot Cboe Global Markets (CBOE) has caught investor attention after a period of mixed short term moves, with the stock down about 1% on the day and roughly 3.7% over the past week. See our latest analysis for Cboe Global Markets. Zooming out, Cboe Global Markets combines a 1-month share price return of 12.64% and year-to-date share price return of 38.74% with a 1-year total shareholder return of 51.82%. This points to strong momentum rather than a short-term bounce. If...

AtaiBeckley, listed as NasdaqGM:ATAI, has launched a Patient Impact Grant Program focused on supporting mental health nonprofits. The program is designed to fund community projects, education initiatives, and research that target improved mental health outcomes. Grants will be reviewed externally and involve collaboration with established mental health organizations. For investors tracking NasdaqGM:ATAI, this move adds a new dimension to how the company engages with the mental health sector...

Red Cat Holdings (RCAT) drew fresh attention after its Blue Ops maritime division moved into full rate production of the Variant 7 uncrewed surface vessel, alongside reports of potential U.S. support for domestic drone technology companies. See our latest analysis for Red Cat Holdings. The latest contract wins and Variant 7 production news arrive during a sharp upswing in sentiment, with a 1-day share price return of 32.61% and a 7-day share price return of 56.70%, while the 1-year total...

Dividend affirmation puts income focus on SM Energy (SM) SM Energy (SM) has drawn fresh attention after its board affirmed a quarterly cash dividend of $0.22 per share, with payment scheduled for June 22, 2026, to holders of record on June 8. See our latest analysis for SM Energy. The dividend decision lands after a powerful run in the stock, with SM Energy’s share price delivering a 34.72% 3 month share price return, a 62.89% year to date share price return, and a 35.71% 1 year total...

In May 2026, Raytheon, an RTX business, secured new U.S. government work ranging from next-generation naval radar software to advanced composable rocket motors, while also beginning deliveries of the Lightweight Command Launch Unit for the Javelin system to the U.S. Army. Together, these programs highlight RTX’s push toward modular, software-driven and adaptable weapon and sensor architectures that can be upgraded and tailored through software rather than repeated hardware redesigns. We’ll...

If you are wondering whether Marathon Petroleum at US$251.33 is still offering value or starting to look stretched, the headline numbers only tell part of the story. The stock has posted returns of 1.2% over the past 7 days, 8.1% over 30 days, 52.2% year to date and 60.2% over the last year, which naturally raises questions about how much of this is already reflected in the current price. Recent attention on large integrated refiners and fuels infrastructure companies has kept Marathon...

If you are wondering whether Cintas stock still justifies its price tag, the key question is how its current market value compares with what the underlying business might reasonably be worth. The share price recently closed at US$173.06, with returns that rose 0.4% over the last 7 days but declined 0.7% over 30 days, 6.4% year to date, and 22.3% over 1 year. The 3 year and 5 year returns sit at 49.3% and 106.7% respectively. Recent coverage has focused on Cintas as a long term compounder in...

LiveRamp Holdings (RAMP) has drawn fresh attention after a recent swing in performance, with the stock up about 26% over the past month and roughly 38% in the past 3 months. See our latest analysis for LiveRamp Holdings. That recent surge sits alongside a 37.1% year to date share price return and a 15.2% total shareholder return over 1 year. This suggests momentum has been building after a slower longer term record that includes a 23.4% total shareholder return decline over 5 years. If...

Magnachip Semiconductor recently announced that it showcased its Medium-Voltage MOSFET portfolio for AI server, data center, and industrial power systems at PCIM Europe 2026 in Nuremberg, Germany, highlighting solutions based on Shielded-Gate Trench technology across applications such as PSUs, HPC, solar inverters, and broader automotive and industrial power platforms. This focus on high-efficiency, high-density power architectures for AI infrastructure underscores how Magnachip is leaning...

Earlier this month, Xometry, Inc. announced that Lukas Biewald, co-founder and former CEO of Weights & Biases and current SVP of AI Initiatives at CoreWeave, joined its Board of Directors and was appointed to the Nominating and Corporate Governance Committee, effective May 20, 2026. By adding a board member whose career focuses on AI infrastructure and developer platforms, Xometry is signaling a deeper commitment to AI-driven product and operational innovation. We’ll now examine how bringing...

On May 28, 2026, Ambarella, Inc. reported first-quarter sales of US$100.36 million and a net loss of US$18.09 million, issued second-quarter revenue guidance of US$105.0–111.0 million, and Hanwha Group announced a long-term edge AI technology agreement with Ambarella valued at over US$800 million across more than ten years. This multi-generational partnership, spanning video security, robotics, industrial automation, and life sciences, positions Ambarella’s CVflow-based edge AI platform and...

IonQ stock performance snapshot Quantum computing company IonQ (IONQ) has drawn fresh attention after recent trading, with the stock closing at US$70.14. Its returns over the past month and past three months were far above its one-day move of 7.2%. See our latest analysis for IonQ. The recent 7.2% one day share price move builds on strong momentum, with a 30 day share price return of 62.8% and a very large 5 year total shareholder return. If IonQ’s run has you thinking about where else...

DigitalOcean Holdings (DOCN) is back in focus after Hippocratic AI reported its Polaris system reached 10 million patient calls with a 99.9% clinical safety score, all running on DigitalOcean's AI Native Cloud powered by NVIDIA GPUs. See our latest analysis for DigitalOcean Holdings. Despite a 4.1% decline in the 7 day share price return, DigitalOcean’s recent news flow and a 60.9% 30 day share price return suggest momentum has been building, with a very large 1 year total shareholder return...

Why Symbotic stock is drawing fresh attention Symbotic (SYM) is back on many watchlists after a sharp single day share price drop of about 9%, prompting investors to reassess how the warehouse automation specialist is currently being valued. See our latest analysis for Symbotic. That one day share price decline sits within a wider pullback, with Symbotic’s share price down 14.49% over 30 days and 24.76% year to date. However, the 1 year total shareholder return is 68.66%, so recent momentum...

Why Natural Resource Partners Is On Investors’ Radar Natural Resource Partners (NRP) has drawn investor attention after recent trading saw the stock close at $105.50. This has prompted a closer look at how its mineral rights and soda ash businesses support its current valuation. See our latest analysis for Natural Resource Partners. Recent trading has been mixed, with the share price return down about 10% over the past month and 13% over the past quarter. By contrast, the year-to-date share...

Monolithic Power Systems (MPWR) is back in focus after reporting strong first quarter results, with earnings and revenue beating estimates and fresh momentum tied to AI infrastructure and communications demand. See our latest analysis for Monolithic Power Systems. The recent Q1 beat comes on top of a powerful run, with the share price at US$1,633.17 and a year to date share price return of 74.43%. The 1 year total shareholder return of 141.74% and 5 year total shareholder return above 4x...

Growing physician adoption and patient referrals for Casgevy are putting CRISPR Therapeutics (CRSP) back in focus, as the company reports a narrower Q1 2026 loss and highlights multiple gene editing milestones ahead. See our latest analysis for CRISPR Therapeutics. CRISPR Therapeutics’ recent Q1 update and growing Casgevy uptake appear to be feeding into short term momentum, with a 1 day share price return of 5.32% and a 7 day share price return of 12.99%. However, the 90 day share price...

Abbott Laboratories (ABT) is back in focus after winning European clearance for its Libre Duo glucose ketone sensors and securing approval for its Ultreon 3.0 AI coronary imaging software. See our latest analysis for Abbott Laboratories. Despite the fresh regulatory wins for Libre Duo and Ultreon 3.0, Abbott Laboratories’ share price is down 30.5% year to date and the 1 year total shareholder return has declined 33.7%. This suggests recent momentum has faded even as product news keeps...

Event driven interest in Zeta Global Holdings stock Zeta Global Holdings (ZETA) is drawing fresh attention after joining Snowflake’s Open Semantic Interchange initiative and releasing a Forrester Consulting study on loyalty data, spotlighting its role in AI driven marketing and data interoperability. See our latest analysis for Zeta Global Holdings. Those AI and data interoperability announcements land alongside strong recent momentum, with the stock posting a 19.1% 90 day share price return...